RAPT Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC RAPT

Report date

3/31/2025

Quarter

2025 Q1

Filed

9/15/2025

Shares

150,946

Value ($000)

184

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	9/15/2025	184	0.0%	150,946	3/31/2025
2024 Q4	2/6/2025	112	0.0%	70,979	12/31/2024
2024 Q3	11/12/2024	143	0.0%	70,946	9/30/2024
2024 Q2	8/12/2024	635	0.0%	208,138	6/30/2024
2024 Q1	5/9/2024	2,116	0.0%	235,656	3/31/2024
2023 Q4	2/6/2024	5,826	0.0%	234,439	12/31/2023
2023 Q3	11/8/2023	3,686	0.0%	221,789	9/30/2023
2023 Q2	8/10/2023	3,700	0.0%	197,845	6/30/2023
2023 Q1	5/12/2023	3,578	0.0%	194,966	3/31/2023
2022 Q4	2/13/2023	3,390	0.0%	171,187	12/31/2022
2022 Q3	11/14/2022	4,006	0.0%	166,487	9/30/2022
2022 Q2	8/15/2022	2,782	0.0%	152,418	6/30/2022
2022 Q1	5/13/2022	3,207	0.0%	145,818	3/31/2022
2021 Q4	2/11/2022	5,219	0.0%	142,073	12/31/2021
2021 Q3	11/16/2021	4,352	0.0%	140,134	9/30/2021
2021 Q2	8/16/2021	2,568	0.0%	80,760	6/30/2021
2021 Q1	5/17/2021	1,466	0.0%	66,003	3/31/2021
2020 Q4	2/16/2021	1,311	0.0%	66,345	12/31/2020
2020 Q3	11/13/2020	2,106	0.0%	65,397	9/30/2020
2020 Q2	8/20/2020	1,502	0.0%	51,756	6/30/2020
2020 Q1	5/15/2020	631	0.0%	29,632	3/31/2020
2019 Q4	2/7/2020	448	0.0%	16,197	12/31/2019